학술논문

Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial
Document Type
Article
Source
In The Lancet Oncology June 2017 18(6):743-754
Subject
Primary Research
Articles
Language
ISSN
1470-2045